Sarepta Therapeutics (SRPT) Shares Repurchased (2018 - 2026)

Sarepta Therapeutics has reported Shares Repurchased for 9 years, with the latest figure at $33.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased fell 27.67% year-over-year to $33.7 million; the trailing twelve-month figure through Mar 2026 stood at $91.7 million (down 39.36% YoY), and the FY2025 full-year result was $25.0 million, changed N/A from the prior year.
• Shares Repurchased for Q1 2026 stood at $33.7 million, up from $16.4 million in the prior quarter.
• The five-year high for Shares Repurchased was $102.9 million in Q2 2022, with the low at -$136.7 million in Q4 2023.
• Average Shares Repurchased over 5 years is $34.7 million, with a median of $46.6 million recorded in 2025.
• Year-over-year, Shares Repurchased jumped 255.18% in 2022 and plunged 370.62% in 2023.
• Tracing SRPT's Shares Repurchased over 5 years: stood at $50.5 million in 2022, then sank by 370.62% to -$136.7 million in 2023, then surged by 135.85% to $49.0 million in 2024, then slumped by 66.54% to $16.4 million in 2025, then soared by 105.37% to $33.7 million in 2026.
• The last three Shares Repurchased figures came in at $33.7 million (Q1 2026), $16.4 million (Q3 2025), and $41.6 million (Q2 2025), per Business Quant data.

Peer Comparison